(1)
Frisch, A.; Marino, L.; Alsaadi, D.; Kasarabada, A.; Hua, G.; Ajebo, G.; Medlin, S.; Gul, Z. Cyclophosphamide for the Treatment of Refractory Immune Effector Cell-Associated Neurotoxicity Syndrome Following CD19-Targeted CAR T-Cell Therapy. J Med Cases 2026, 17 (1), 28-31. https://doi.org/10.14740/jmc5211.